Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Traffic safety under agomelatine
2010-023473-18Phase 4Active
- Sponsor
- Inn-Salzach-Klinikum
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of agomelatine in major depressive episode (MDE) and recurrent depressive disorder (RDD) (2 arms), sponsored by Inn-Salzach-Klinikum. Primary endpoints: Discharge from inpatient treatment and Change in psychopathology ratings. Started Dec 2010; status: active.
02
Drugs
agomelatine
03
Conditions
major depressive episode (MDE)recurrent depressive disorder (RDD)
Beyond the preview
Go deeper on 2010-023473-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023473-18.